Streetbeat News

Revenues

CARS

Cars.com has revised its FY24 revenue growth projection to 4.5%-5.5%, down from the previous 6.0%-8.0%. Q3 revenues are expected to be $178M-$181M, below the $185.76M estimate. The company cites the CDK cyber incident and slower AccuTrade Connected subscriptions as factors. Adjusted EBITDA margin for Q3 is expected to be 26.5%-28.5%, and for FY24, it remains at 28.0%-30.0%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:40 am

EXAI

RXRX

Recursion Pharmaceuticals (RXRX) and Exscientia (EXAI) have announced a definitive agreement to combine their capabilities to create a leading end-to-end drug discovery platform. The collaboration is expected to yield 10 clinical readouts in the next 18 months, $200 million in milestone payments over 24 months, and potentially $20 billion overall. The companies have $850 million in cash on hand and anticipate $100 million in annual synergies.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:40 am

WHF

WhiteHorse Finance (NASDAQ:WHF) reported Q2 2024 earnings of $0.40 per share, missing the analyst estimate of $0.44. Sales were $23.482 million, also below the $24.711 million estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:39 am

NTLA

Intellia Therapeutics reported having $939.9 million in cash, cash equivalents, and marketable securities as of June 30, 2024. This amount is expected to fund the company's operations into late 2026.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:39 am

OM

Outset Medical shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:39 am

MLM

Martin Marietta Materials (NYSE:MLM) reported Q2 2024 adjusted EPS of $5.26, missing the analyst estimate of $5.40. Sales were $1.764 billion, also below the $1.846 billion estimate and down 3.13% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:39 am

KELYB

Kelly Services (NASDAQ:KELYB) reported Q2 earnings of $0.71 per share, a 97.22% increase from $0.36 per share YoY. However, sales decreased by 13.06% to $1.06 billion from $1.22 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:38 am

LIND

Lindblad Expeditions has reaffirmed its FY24 tour revenues forecast of $610M - $630M, compared to the estimated $621.35M. The company also projects an adjusted EBITDA of $88M - $98M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:38 am

SYRA

Syra Health (NASDAQ:SYRA) reported Q2 earnings per share (EPS) of $(0.21), missing the analyst estimate of $(0.19). However, the company reported sales of $1.97 million, beating the estimate of $1.79 million. This represents a significant year-over-year sales increase of 101.17%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:36 am

WRBY

Warby Parker shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:35 am